Verici DX (VRCI) Share Price

Health Care Sector


NOTE: This is based on 15 open tips for Verici DX (VRCI)


Verici DX (VRCI)
Latest Quote Price

0.20p

Verici DX (VRCI)
Price Change (%)

-0.81%


Latest Bid : 0.20p Latest Ask : 0.21p
High Today : 0.20p Low Today : 0.20p
This Years High : 0.88p This Years Low : 0.20p
Volume : 615,016 MKT Cap : £0.48M
Trading Velocity : Premium Only Activity Score : Premium Only
Consensus Score : Premium Only Momentum Score : Premium Only

Verici DX (VRCI) Overview

Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.

Verici DX (VRCI) Latest Tips

Type Tipster SectorScore Start date Performance
Avoid Steve Moore Premium Only 2026-06-05 16:10:00 05/06/2026 41.43%
Avoid Steve Moore Premium Only 2026-04-16 16:30:00 16/04/2026 59.00%
Sell Steve Moore Premium Only 2025-07-21 11:25:00 21/07/2025 59.00%
Sell Steve Moore Premium Only 2025-06-11 16:25:00 11/06/2025 83.60%
Avoid Steve Moore Premium Only 2025-04-07 11:10:00 07/04/2025 86.33%

You are missing Premium Content from this chart

Please Log In to a premium account or Sign Up today to view premium content.


Verici DX (VRCI) Recent Short Position Updates

Position Date
No active short positions

See more short positions...


Latest Bid : 0.20p Latest Ask : 0.21p
High Today : 0.20p Low Today : 0.20p
This Years High : 0.88p This Years Low : 0.20p
Volume : 615,016 MKT Cap : £0.48M

Verici DX Overview

Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.

NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.


Latest Verici DX Tips

Type Tipster SectorScore Start date Performance
Avoid Steve Moore Premium Only 2026-06-05 16:10:00 05/06/2026 41.43%
Avoid Steve Moore Premium Only 2026-04-16 16:30:00 16/04/2026 59.00%
Sell Steve Moore Premium Only 2025-07-21 11:25:00 21/07/2025 59.00%
Sell Steve Moore Premium Only 2025-06-11 16:25:00 11/06/2025 83.60%
Avoid Steve Moore Premium Only 2025-04-07 11:10:00 07/04/2025 86.33%